.0000000000002023 .. J Clin Rheumatol, 10(7) : 341-6.
Ostrovsky M,Rosenblatt A,Iriqat S,Shteiwi A,Sharon Y,Kramer M .2023 .Ocular behcet disease-clinical manifestations, treatments and outcomes according to age at disease onset. Biomedicines, 10(2) : 624.
AboAloioun ZI,Mostafa NM,Ismael EO,Kamal D. .2022 .Clinical manifestations in Behcet s diseased patients: Is it a ected by disease activity?. Egyp J Hosp Med, 260748(1) : 4833-8.
Gul A,Wallace GR,Yazici Y,Hatemi G,Seyahi E,Yazici H .2020 .Genetics of Behcet s disease. , 10 : 16.
Alibaz-Oner F,Direskeneli H. .2021 .Advances in the treatment of Behcet s disease. Curr Rheumatol Rep, 10(6) : 47.
Davatchi F,Jamshidi AR,Banihashemi AT,Gholami J,Forouzanfar MH,Akhlaghi M .2008 .WHO-ILAR COPCORD study (stage 1, urban study. Iran.J Rheumatol, 35(7) : 1384.
Carrio JR,Nucera V,Masala IF,Atzeni F .2021 .Behcet disease: From pathogenesis to novel therapeutic options. Pharmacol Res, 105593 : 105593.
Demirkesen C,Oz B,Goksel S.,Yazici Y,Hatemi G,Seyahi E,Yazici H .2020 .Behcet syndrome: Pathology. , 10 : 12.
Davatchi F,Chams Davatchi C,Shams H,Nadji A,Faezi T,Akhlaghi M .2016 .. Adult Behcet s disease in Iran: Analysis of 6075 patients. Int J Rheum Dis, 10(1) : 12691-185X.
Sakly N,Boumiza R,Hassen SZ,Hamzaoui A,Yahia SB,Amara H .2009 .HLA B27 and HLA B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behcet s disease. Ann NY Acad Sci, 04756(1) : 6632-9.
Nishiyama M,Nakae K,Umehara T. .2001 .A study of familial occurrence of Behcet s disease with and without ocular lesions. Jpn J Ophthalmol, 5155(01) : 00321-5.
Maldini C,LaValley MP,Cheminant M,de Menthon M,Mahr A .2012 .Relationships of HLA-B51 or B5 genotype with Behcet s disease clinical characteristics: Systematic review and meta-analyses of observational studies. Rheumatology, 10(5) : 887-900.